495 related articles for article (PubMed ID: 27653471)
1. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
Sethi MK; Hancock WS; Fanayan S
Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
[TBL] [Abstract][Full Text] [Related]
2. Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines.
Sethi MK; Thaysen-Andersen M; Smith JT; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Jan; 13(1):277-88. PubMed ID: 24295106
[TBL] [Abstract][Full Text] [Related]
3. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
4. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
Sethi MK; Fanayan S
Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype.
Madunić K; Zhang T; Mayboroda OA; Holst S; Stavenhagen K; Jin C; Karlsson NG; Lageveen-Kammeijer GSM; Wuhrer M
Cell Mol Life Sci; 2021 Jan; 78(1):337-350. PubMed ID: 32236654
[TBL] [Abstract][Full Text] [Related]
7. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
8. N-glycomic profiling of colorectal cancer according to tumor stage and location.
Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.
Zhang D; Xie Q; Wang Q; Wang Y; Miao J; Li L; Zhang T; Cao X; Li Y
Glycobiology; 2019 May; 29(5):372-384. PubMed ID: 30698702
[TBL] [Abstract][Full Text] [Related]
10. In-Depth Analysis of the
Wang D; Kuzyk V; Madunić K; Zhang T; Mayboroda OA; Wuhrer M; Lageveen-Kammeijer GSM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902272
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
12. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.
Anugraham M; Jacob F; Everest-Dass AV; Schoetzau A; Nixdorf S; Hacker NF; Fink D; Heinzelmann-Schwarz V; Packer NH
Mol Oncol; 2017 Nov; 11(11):1595-1615. PubMed ID: 28853212
[TBL] [Abstract][Full Text] [Related]
13. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
14. Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1.
Thaysen-Andersen M; Thøgersen IB; Lademann U; Offenberg H; Giessing AM; Enghild JJ; Nielsen HJ; Brünner N; Højrup P
Biochim Biophys Acta; 2008 Mar; 1784(3):455-63. PubMed ID: 18206988
[TBL] [Abstract][Full Text] [Related]
15. Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.
Qin W; Zhang Z; Qin R; Han J; Zhao R; Gu Y; Pan Y; Gu J; Ren S
Anal Chim Acta; 2019 Nov; 1081():112-119. PubMed ID: 31446948
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
17. Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Peng W; Goli M; Mirzaei P; Mechref Y
J Proteome Res; 2019 Oct; 18(10):3731-3740. PubMed ID: 31430160
[TBL] [Abstract][Full Text] [Related]
18. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
19. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
20. Dynamic alterations in serum IgG N-glycan profiles in the development of colitis-associated colon Cancer in mouse model.
Gu Y; Han J; Liu X; Pan Y; Xu X; Sha J; Ren S; Gu J
Biochim Biophys Acta Gen Subj; 2020 Oct; 1864(10):129668. PubMed ID: 32553689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]